Earnings in 4d
GMRS · NYSE · Medical - Care Facilities

GMR Solutions (GMRS)

Coordinates ground and air medical transport, care navigation and repatriation.

$12.64
Pre-market−0.16 (−1.25%)
At close$12.80(−1.31%)
  1. GMR Solutions Q2 Earnings Call Highlights

    MarketBeat

    GMR Solutions NYSE: GMRS reported second-quarter revenue growth and higher demand for its core emergency services, while adjusted EBITDA declined from the prior year as the company lapped favorable revenue estimate adjustments tied to older No Surprises Act claims and recorded IPO-related expenses.

  2. GMR Solutions Inc. (GMRS) Q2 2026 Earnings Call Transcript

    Seeking Alpha

    GMR Solutions Inc. (GMRS) Q2 2026 Earnings Call Transcript

  3. GMR Solutions Inc. (GMRS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

    Zacks Investment Research

    While the top- and bottom-line numbers for GMR Solutions Inc. (GMRS) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

  4. GMR Solutions Inc. Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Reaffirms Full Year 2026 Guidance

    Business Wire

    LEWISVILLE, Texas--(BUSINESS WIRE)--GMR Solutions Inc. (“GMR” or the “Company”) (NYSE: GMRS), the nation's largest provider of emergency medical services (“EMS”), today announced financial results for the three and six months ended June 30, 2026, and updated its full year 2026 financial guidance. “We are pleased with our second quarter results, which reflect operational execution and continued momentum across our business,” said Nick Loporcaro, Chairman and Chief Executive Officer at GMR. “We e.

  5. GMR Solutions Inc. Sets Second Quarter 2026 Earnings Call

    Business Wire

    LEWISVILLE, Texas--(BUSINESS WIRE)--GMR Solutions Inc. Sets Second Quarter 2026 Earnings Call.

  6. GMR Solutions Strengthens Board with Appointments of Healthcare Leaders Dr. Amar Desai and Ellen Zane

    Business Wire

    LEWISVILLE, Texas--(BUSINESS WIRE)--GMR Solutions, Inc. (NYSE: GMRS) (GMRS), the nation's leading emergency medical services (EMS) provider, announced the appointments of Dr. Amar Desai and Ellen Zane to its Board of Directors, effective July 1, 2026. The appointments bring decades of leadership experience across healthcare delivery, value-based care, health system operations, human capital management, and corporate governance, further strengthening the Board as Global Medical Response (GMR) ad.

  7. GMR Solutions: The Post-IPO Discount Looks Too Harsh

    Seeking Alpha

    GMR Solutions Inc. is rated a buy, leveraging national scale in EMS and trading at a discounted ~7.5x NTM P/E. GMRS's scale enables contract wins, new market growth, and competitive renewal advantages, driving incremental revenue and margin optimization. Strategic focus on higher-acuity, better-reimbursed services and programs like Nurse Navigation is improving revenue quality and unit economics.

  8. GMR Solutions Inc. (GMRS) Q1 2026 Earnings Call Transcript

    Seeking Alpha

    GMR Solutions Inc. (GMRS) Q1 2026 Earnings Call Transcript

  9. GMR Solutions Inc. Reports First Quarter 2026 Financial Results and Establishes Full Year 2026 Guidance

    Business Wire

    LEWISVILLE, Texas--(BUSINESS WIRE)--Q1 Earnings call.

  10. Why This 911 Ambulance IPO Could Be a Long-Term Winner

    The Street

    A 911 ambulance IPO just hit the market — Global Medical Response CEO makes the case for why this essential service is a long‑term growth story: #IPO #stockmarket #nyse Subscribe | http://t.st/TheStreetTV Earn. Live. Invest.

  11. GMR Solutions Inc. Announces Launch of its Initial Public Offering

    GlobeNewsWire

    LEWISVILLE, TEXAS, May 04, 2026 (GLOBE NEWSWIRE) -- LEWISVILLE, TEXAS, May 4, 2026 – GMR Solutions Inc. (“GMR”) today announced the launch of its initial public offering of 31,914,893 shares of its Class A common stock. The initial public offering price for the Class A common stock is expected to be between $22.00 and $25.00 per share.